Related Experiment Video
Updated: Jun 18, 2026
06:57
The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections
Published on: May 8, 2017
Upper airway 2: Bronchiectasis, cystic fibrosis and sinusitis
M R Loebinger1, D Bilton, R Wilson
1Host Defence Unit, Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK.
Thorax
|December 3, 2009
Summary
Sinonasal disease is common in bronchiectasis and cystic fibrosis, sharing similar causes with lung issues. This review explores the connection between upper and lower airway conditions and their treatment.
Area of Science:
- Otolaryngology
- Pulmonology
- Medical Research
Background:
- Sinonasal disease frequently co-occurs with chronic lung conditions like bronchiectasis and cystic fibrosis.
- The etiology and pathophysiology of sinonasal disease are often linked to those of chronic lung disease.
- Limited literature exists on managing sinonasal conditions within the context of bronchiectasis.
Purpose of the Study:
- To review the current understanding of sinonasal disease in patients with bronchiectasis and cystic fibrosis.
- To explore the potential bidirectional influence between upper and lower airway health.
- To highlight the need for integrated management strategies.
Main Methods:
- Literature review of studies on sinonasal disease in bronchiectasis and cystic fibrosis.
- Analysis of the shared pathophysiology between sinonasal and lower airway chronic diseases.
- Discussion of clinical implications and treatment considerations.
Main Results:
- Sinonasal disease is a significant comorbidity in bronchiectasis and cystic fibrosis.
- Evidence suggests sinonasal disease can negatively impact bronchial conditions.
- Shared inflammatory pathways likely connect upper and lower airway pathologies.
Conclusions:
- Integrated management of sinonasal and lower airway disease is crucial for patients with bronchiectasis and cystic fibrosis.
- Further research is needed to elucidate the precise mechanisms of interaction and optimize treatment.
- Addressing sinonasal health may improve outcomes for chronic lung diseases.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:23Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
01:29Anatomy of Respiratory System I: Upper Respiratory Tract
The upper respiratory tract plays a vital role in the respiratory system, comprising several structures that facilitate air intake and prepare air for the lungs. It also serves as the first line of defense against pathogens and particles. This tract includes the nose and nasal cavity, the oral cavity, the paranasal sinuses, and the pharynx, each with specific functions and features.
Nose and nasal cavity
The nose and nasal cavity represent the main external openings of the respiratory tract.
Nose and nasal cavity
The nose and nasal cavity represent the main external openings of the respiratory tract.
01:29Microbiota of the Respiratory Tract
The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:24Cystic Fibrosis: Management
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Sinus disease and chronic sinusitis...